ЖурналыПодпискаАрхивКнигиПроектыО насРекламаДоставка/ОплатаКонтакты
+7 (495) 482-43-29
  • Главная
  • / Журналы
  • / Вернуться в журнал
  • / Содержание номера
  • / Статья
Ешь и дыши

Ешь и дыши

Авторы:
Сироткина К.И.

Журнал: Non nocere. Новый терапевтический журнал. 2025;(10):34-37.

Прочитано: 503 раза

Резюме

Нутритивный статус при ХОБЛ. Возможности коррекции.

Дата публикации: 18.11.2025

Литература / References
  1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10111975/
  2. Schols AM, Ferreira IM, Franssen FM, et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J. 2014 Dec;44(6):1504-1520. https://doi.org/10.1183/09031936.00070914
  3. Volakova E, Koblizek V, Svoboda M, et al. Nutritional status and muscle mass loss in patients with COPD, association with lung function, symptoms, comorbidities and long-term survival: data from the National Database Study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2024 Feb 5. https://doi.org/10.5507/bp.2025.001
  4. Beijers RJHCG, Steiner MC, Schols AMWJ. The role of diet and nutrition in the management of COPD. Eur Respir Rev. 2023 Jun 7;32(168):230003. https://doi.org/10.1183/16000617.0003-2023
  5. Jaitovich A, Barreiro E. Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients. Am J Respir Crit Care Med. 2018 Jul 15;198(2):175-186. https://doi.org/10.1164/rccm.201710-2140CI
  6. Pinto LM, Alghamdi M, Benedetti A, Zaihra T, Landry T, Bourbeau J. Derivation and validation of clinical phenotypes for COPD: a systematic review. Respir Res. 2015 Apr 18;16(1):50. https://doi.org/10.1186/s12931-015-0208-4
  7. Kim T, Shin SH, Kim H, et al. Longitudinal BMI change and outcomes in Chronic Obstructive Pulmonary Disease: a nationwide population-based cohort study. Respir Res. 2024 Mar 30;25(1):150. https://doi.org/10.1186/s12931-024-02788-0
  8. Aldhahir AM, Rajeh AMA, Aldabayan YS, et al. Nutritional supplementation during pulmonary rehabilitation in COPD: A systematic review. Chron Respir Dis. 2020 Jan–Dec;17:1479973120904953. https://doi.org/10.1177/1479973120904953
  9. Agustí A, Bafadhel M, Beasley R, et al. Precision medicine in airway diseases: moving to clinical practice. Eur Respir J. 2017 Oct 19;50(4):1701655. https://doi.org/10.1183/13993003.01655-2017
  10. Ferreira IM, Brooks D, White J, Goldstein R. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD000998. https://doi.org/10.1002/14651858
  11. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64. https://doi.org/10.1164/rccm.201309-1634ST
  12. Tuna T, Samur G. The Role of Nutrition and Nutritional Supplements in the Prevention and Treatment of Malnutrition in Chronic Obstructive Pulmonary Disease: Current Approaches in Nutrition Therapy. Curr Nutr Rep. 2025 Jan 25;14(1):21. https://doi.org/10.1007/s13668-025-00613-8
  13. Savino-Lloreda P, López-Daza D, Casas-Herrera A. Medical nutrition therapy in chronic obstructive pulmonary disease: A narrative review. Nutr Clin Pract. 2025 Aug;40(4):793-804. https://doi.org/10.1002/ncp.11329
  14. Conway V, Hukins C, Sharp S, Collins PF. Nutritional Support in Malnourished Outpatients with Chronic Obstructive Pulmonary Disease (COPD): A Randomized Controlled Pilot Study. Nutrients. 2024 May 30;16(11):1696. https://doi.org/10.3390/nu16111696
  15. Галимова А.Р., Асланова М.А. Нутритивная поддержка людей с хронической обструктивной болезнью легких. Международный журнал гуманитарных и естественных наук. 2023;6-2(81):62-67. https://doi.org/10.24412/2500-1000-2023-6-2-62-68
  16. Alibakhshi E, Shirvani H. Nutritional Status in Patients with Chronic Obstruction Pulmonary Disease (COPD) – Review. EC Nutr. 2015;2(1):267-274.
  17. Calder PC, Laviano A, Lonnqvist F, Muscaritoli M, Öhlander M, Schols A. Targeted medical nutrition for cachexia in chronic obstructive pulmonary disease: a randomized, controlled trial. J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):28-40. https://doi.org/10.1002/jcsm.12228
  18. Huang WJ, Ko CY. Systematic review and meta-analysis of nutrient supplements for treating sarcopenia in people with chronic obstructive pulmonary disease. Aging Clin Exp Res. 2024 Mar 14;36(1):69. https://doi.org/10.1007/s40520-024-02722-w
  19. De Brandt J, Beijers RJHCG, et al. Update on the Etiology, Assessment, and Management of COPD Cachexia: Considerations for the Clinician. Int J Chron Obstruct Pulmon Dis. 2022 Nov 18;17:2957-2976. https://doi.org/10.2147/COPD.S334228
  20. Casaburi R, Nakata J, Bistrong L, Torres E, Rambod M, Porszasz J. Effect of Megestrol Acetate and Testosterone on Body Composition and Hormonal Responses in COPD Cachexia. Chronic Obstr Pulm Dis. 2015 Nov 9;3(1):389-397. https://doi.org/10.15326/jcopdf.3.1.2015.0128
  21. Tabei SS, Kataria R, Hou S, et al. Testosterone replacement therapy in patients with cachexia: a contemporary review of the literature. Sex Med Rev. 2024 Jun 26;12(3):469-476. https://doi.org/10.1093/sxmrev/qeae031
  22. Carson EL, Pourshahidi LK, Madigan SM, et al. Vitamin D status is associated with muscle strength and quality of life in patients with COPD: a seasonal prospective observation study. Int J Chron Obstruct Pulmon Dis. 2018 Aug 28;13:2613-2622. https://doi.org/10.2147/COPD.S166919
  23. Jolliffe DA, Greenberg L, Hooper RL, et al. Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials. Thorax. 2019 Apr;74(4):337-345. https://doi.org/10.1136/thoraxjnl-2018-212092
  24. McDonald VM, Gibson PG, Scott HA, et al. Should we treat obesity in COPD? The effects of diet and resistance exercise training. Respirology. 2016 Jul;21(5):875-882. https://doi.org/10.1111/resp.12746
  25. Au DH, Gleason E, Hunter-Merrill R, et al. Lifestyle Intervention and Excess Weight in Chronic Obstructive Pulmonary Disease (COPD): INSIGHT COPD Randomized Clinical Trial. Ann Am Thorac Soc. 2023 Dec;20(12):1743-1751. https://doi.org/10.1513/AnnalsATS.202305-458OC
  26. Chami-Peña S, Caballero-Vázquez A, Mebrive-Jiménez MJ, et al. Therapeutic Management in Patients with Chronic Obstructive Pulmonary Disease Who Are Overweight or Obese: A Systematic Review and Meta-Analysis. J Clin Med. 2025 Feb 13;14(4):1230. https://doi.org/10.3390/jcm14041230
  27. Wang W, Mei A, Qian H, et al. The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2023 Feb 15;18:129-137. https://doi.org/10.2147/COPD.S393323
  28. Altintas Dogan AD, Hilberg O, Hess S, Jensen TT, Bladbjerg EM, Juhl CB. Respiratory Effects of Treatment with a Glucagon-Like Peptide-1 Receptor Agonist in Patients Suffering from Obesity and Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2022 Feb 22;17:405-414. https://doi.org/10.2147/COPD.S350133
  29. See XY, Xanthavanij N, Lee YC, et al. Pulmonary outcomes of incretin-based therapies in COPD patients receiving single-inhaler triple therapy. ERJ Open Res. 2025 Apr 14;11(2):00803-2024. https://doi.org/10.1183/23120541.00803-2024
slide-cover
slide-cover
slide-cover
slide-cover
Издательство «Медиа Сфера»
РекламаДоставка/ОплатаО насКонтактыОбучение для редакцийПолитика конфиденциальностиПолитика обработки персональных данныхПубличная оферта на реализацию издательской продукции
ЖурналыПодпискаАрхивКнигиПроекты
  • RuStore

© 1998-2026

  • Телефоны издательства:

  • +7 (495) 482-41-18
  • +7 (495) 482-43-29

  • Прямой телефон отдела подписки
    (только по вопросам заказов и доставки журналов)

  • +7 (800) 250-18-12

  • пн-пт с 10:00 до 18:00

  • Telegram
  • VK
info@mediasphera.ru

  • Почтовый адрес:

  • Издательство «Медиа Сфера»,
    а/я 54, Москва, Россия, 127238

  • RuStore

© 1998-2026